 |
Sir Ronald Claus Hampel (born 31 May 1932) [1] is an English former businessman, who was chief executive and chairman of ICI in the 1990s. He planned and oversaw the Zeneca de-merger in June 1993.
|
Sir Ronald Claus Hampel (born 31 May 1932) [1] is an English former businessman, who was chief executive and chairman of ICI in the 1990s. He planned and oversaw the Zeneca de-merger in June 1993.
He was born in Shropshire, the son of Karl Hampel (29 May 1898 -10 February 1960) and Rutgard Hauck (8 August 1904 - 21 April 1975). His brothers were born in 1934 and 1935. He grew up in Allscott.
He attended Corpus Christi College, Cambridge where he obtained an MA in Modern Languages and Law.
He started at ICI in 1955. He joined the ICI board in 1985.
In the 1990s, ICI was the world's largest manufacturer of paint (after buying Glidden Paints in 1986) and explosives (after buying Atlas Powder Company in 1990).
In February 1991 it had been decided to streamline the company around seven core business areas. Later in 1991 it was realised that there was most synergy around two distinct main core areas. He became chief operating officer on Tuesday 1 October 1991. [2]
On 29 July 1992 it was officially decided to de-merge the business into ICI and another company, possibly to be known as ICI Biosciences. In late November 1992 it had been decided to call the new company Zeneca, under Sir David Barnes (1936-2020). The company was originally to be called Zenica. The main products of Zeneca included Hibitane (Chlorhexidine), the world's best-selling hospital antiseptic since the 1950s. DNA fingerprinting and DNA paternity testing had been mostly first developed by Cellmark Diagnostics (now called Orchid Cellmark), which became part of Zeneca; to this day it is one of the main UK DNA profiling companies; it was the world's first commercial DNA testing laboratory. For 1991, Zeneca had larger sales than Pfizer.
He became chief executive and deputy-chairman of ICI in 1993. The reformed £2.5bn ICI would largely make paint and explosives. Zeneca would be worth £6bn. [3] Zeneca split in June 1993.
He was appointed chairman in April 1995. In 1996 he was paid £863,000 [4] In 1997 ICI bought Unilever's chemical division for £4.8bn. He was chairman until Thursday 22 April 1999, at the annual shareholders meeting, with Friends of the Earth in uninvited attendance.
In January 1998 he was responsible for the Hampel Report, for corporate governance in the United Kingdom, set up by the Financial Reporting Council in November 1995.
He was knighted in the 1995 New Year Honours.
He married in 1957 in Somerset. He has twin sons (born 1962), another son (born 1960) and one daughter (born 1958). He lives in rural West Sussex.
Imperial Chemical Industries (ICI) was a British chemical company. It was, for much of its history, the largest manufacturer in Britain. It was formed by the merger of four leading British chemical companies in 1926. Its headquarters were at Millbank in London. ICI was a constituent of the FT 30 and later the FTSE 100 indices.
Akzo Nobel N.V., stylized as AkzoNobel, is a Dutch multinational company which creates paints and performance coatings for both industry and consumers worldwide. Headquartered in Amsterdam, the company has activities in more than 150 countries. AkzoNobel is the world's third-largest paint manufacturer by revenue after Sherwin-Williams and PPG Industries.
Sir Howard Stringer is a Welsh-American businessman. He had a 30-year career at CBS, culminating in him serving as the president of CBS News from 1986 to 1988, then president of CBS from 1988 to 1995. He served as chairman of the board, chairman, president and CEO of Sony Corporation from 2005 to 2012. He is also the head of the board of trustees of the American Film Institute and now serves as a non-executive director of the BBC. He was knighted in 1999.
Zeneca was a British multinational pharmaceutical company headquartered in London, United Kingdom. It was formed in June 1993 by the demerger of the pharmaceuticals and agrochemicals businesses of Imperial Chemical Industries into a separate company listed on the London Stock Exchange.
Sir Richard Greenbury was an English businessman, and chairman and chief executive of the British retailer Marks and Spencer from 1988 to 1999. During his tenure, the company continued to grow until its profits peaked in 1997 and 1998 when it was the second most profitable retailer in the world after Wal-Mart, and the ninth largest company in Britain. After resigning as executive chairman, he was succeeded by Peter Salsbury.
Louis Schweitzer is a Swiss businessman who is a former chairman of the board of Groupe Renault, first taking the post on 27 May 1992, succeeding Raymond Lévy. He was also CEO from 1992 to 2005. He was in addition Chairman of AstraZeneca until 8 June 2012 where he was appointed as a Director on 11 March 2004. He is a non-executive director of BNP Paribas, Electricité de France, Veolia Environnement, Volvo AB and L'Oréal, and Vice-Chairman of the Supervisory Board of Philips Electronics NV
Sir John Harvey-Jones MBE was an English businessman. He was the chairman of Imperial Chemical Industries from 1982 to 1987. He was best known by the public for his BBC television show, Troubleshooter, in which he advised struggling businesses.
Sir Thomas Fulton Wilson McKillop, FRS, FRSE is a Scottish chemist, who was CEO of AstraZeneca PLC from 1999 until 2006 and chairman of the RBS Group from 2006 until 2008.
Orchid Cellmark Ltd is a UK based DNA and forensic testing company with a history of UK and US ownership.
Laboratory Corporation of America Holdings, more commonly known as Labcorp, is an American healthcare company headquartered in Burlington, North Carolina. It operates one of the largest clinical laboratory networks in the world, with a United States network of 36 primary laboratories. Before a merger with National Health Laboratory in 1995, the company operated under the name Roche BioMedical. Labcorp performs its largest volume of specialty testing at its Center for Esoteric Testing in Burlington, North Carolina, where the company is headquartered. As of 2018, Labcorp processes 2.5 million lab tests weekly.
Sir Denys Hartley Henderson was a British businessman. He was chairman of ICI from 1987 to 1995.
Dalgety plc—as Dalgety and Company—was for more than a century a major pastoral and agricultural company or stock and station agency in Australia and New Zealand. Controlled from London it was listed on the London Stock Exchange and Australasian exchanges.
Sir Frank Ewart Smith FRS, known as Sir Ewart Smith was a scholar, military scientist, and technical director, then Deputy Chairman of Imperial Chemical Industries
Alderley Park was a country estate at Nether Alderley, Cheshire, England, between Macclesfield and Knutsford. It was the residence of the Stanley family of Alderley from the 1500s. It became the headquarters of ICI Pharmaceuticals in the 1950s. It was purchased from AstraZeneca by Bruntwood in 2014. The site has an international reputation as a home for bio and life sciences.
Sir Robert Malpas was a British engineer and businessman. Much of his career was spent with ICI. He was Chairman of ICI Europa Ltd and a member of the ICI Main Board before becoming a managing director of BP, Chairman of PowerGen and the Cookson Group, and Co-Chairman of Eurotunnel.
Hexagon Tower is a specialist science and technology facility located in Blackley, Manchester, England.
The chemical industry in the United Kingdom is one of the UK's main manufacturing industries. At one time, the UK's chemical industry was a world leader. The industry has also been environmentally damaging, and includes radioactive nuclear industries.
The New Frontiers Science Park is a science park in Essex, on a redeveloped research site of GlaxoSmithKline (GSK).
Unilever Gloucester is a large food manufacturing site in the north-east of Gloucester, England, that produces all of the makes of Unilever ice cream for the UK.
Sir Brian Gerald Pearse is a British businessman, and the former chief executive of Midland Bank in the early 1990s.